Globus Medical Inc [GMED] stock is trading at $76.06, up 3.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GMED shares have gain 5.43% over the last week, with a monthly amount drifted -5.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Globus Medical Inc [NYSE: GMED] stock has seen the most recent analyst activity on January 10, 2025, when BofA Securities upgraded its rating to a Neutral but kept the price target unchanged to $97 for it. Previously, Morgan Stanley upgraded its rating to Overweight on December 02, 2024, and elevated its price target to $100. On August 07, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $78 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $80 on May 20, 2024. BTIG Research upgraded its rating to a Buy but $60 remained the price target by the analyst firm on March 18, 2024. ROTH MKM started tracking with a Buy rating for this stock on October 20, 2023, and assigned it a price target of $75. In a note dated September 19, 2023, Stifel upgraded an Buy rating on this stock but restated the target price of $61.
Globus Medical Inc [GMED] stock has fluctuated between $49.33 and $94.93 over the past year. Currently, Wall Street analysts expect the stock to reach $100 within the next 12 months. Globus Medical Inc [NYSE: GMED] shares were valued at $76.06 at the most recent close of the market. An investor can expect a potential return of 31.48% based on the average GMED price forecast.
Analyzing the GMED fundamentals
Globus Medical Inc [NYSE:GMED] reported sales of 2.52B for the trailing twelve months, which represents a growth of 6.61%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.05. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.71 points at the first support level, and at 73.35 for the second support level. However, for the 1st resistance point, the stock is sitting at 76.74, and for the 2nd resistance point, it is at 77.41.
Ratios To Look Out For
For context, Globus Medical Inc’s Current Ratio is 2.54. Further, the Quick Ratio stands at 1.77, while the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 4.83, the price to book ratio is 2.50 and price to earnings (TTM) ratio is 102.18.
Transactions by insiders
Recent insider trading involved RHOADS ANN D, Director, that happened on Feb 28 ’25 when 7500.0 shares were sold. Director, RHOADS ANN D completed a deal on Feb 28 ’25 to buy 7500.0 shares. Meanwhile, COO, CFO Pfeil Keith W sold 14167.0 shares on Jan 10 ’25.
